nodes	percent_of_prediction	percent_of_DWPC	metapath
Methantheline—CHRM1—epilepsy syndrome	0.513	1	CbGaD
Methantheline—Protriptyline—Carbamazepine—epilepsy syndrome	0.4	1	CrCrCtD
Methantheline—Propantheline—CHRM3—epilepsy syndrome	0.00138	0.224	CrCbGaD
Methantheline—Propantheline—CHRM1—epilepsy syndrome	0.00129	0.209	CrCbGaD
Methantheline—Propantheline—CHRM2—epilepsy syndrome	0.00105	0.171	CrCbGaD
Methantheline—Oxyphenonium—CHRM3—epilepsy syndrome	0.000934	0.151	CrCbGaD
Methantheline—Oxyphenonium—CHRM1—epilepsy syndrome	0.000871	0.141	CrCbGaD
Methantheline—Protriptyline—SLC6A4—epilepsy syndrome	0.000289	0.0469	CrCbGaD
Methantheline—Protriptyline—CYP2D6—epilepsy syndrome	0.000203	0.0329	CrCbGaD
Methantheline—Protriptyline—ABCB1—epilepsy syndrome	0.000145	0.0235	CrCbGaD
Methantheline—CHRM1—Signaling by GPCR—GRM8—epilepsy syndrome	3.98e-05	0.000498	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CX3CR1—epilepsy syndrome	3.93e-05	0.000491	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	3.87e-05	0.000484	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CHRM2—epilepsy syndrome	3.85e-05	0.000482	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CX3CL1—epilepsy syndrome	3.85e-05	0.000482	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—BDKRB1—epilepsy syndrome	3.85e-05	0.000482	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ACKR4—epilepsy syndrome	3.85e-05	0.000481	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GNAO1—epilepsy syndrome	3.8e-05	0.000475	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—OPRD1—epilepsy syndrome	3.8e-05	0.000475	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	3.79e-05	0.000473	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—GAL—epilepsy syndrome	3.77e-05	0.000471	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CDC42—epilepsy syndrome	3.77e-05	0.000471	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—GABBR1—epilepsy syndrome	3.75e-05	0.000469	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CHRM3—epilepsy syndrome	3.73e-05	0.000466	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—GRM5—epilepsy syndrome	3.73e-05	0.000466	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AVP—epilepsy syndrome	3.65e-05	0.000456	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PDYN—epilepsy syndrome	3.64e-05	0.000455	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CCR7—epilepsy syndrome	3.64e-05	0.000455	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GRM1—epilepsy syndrome	3.64e-05	0.000455	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HRH3—epilepsy syndrome	3.59e-05	0.000449	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	3.59e-05	0.000449	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—OPRM1—epilepsy syndrome	3.54e-05	0.000442	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	3.51e-05	0.000438	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CHRM2—epilepsy syndrome	3.51e-05	0.000438	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SSTR5—epilepsy syndrome	3.48e-05	0.000435	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SSTR4—epilepsy syndrome	3.48e-05	0.000435	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—AVP—epilepsy syndrome	3.47e-05	0.000433	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GAL—epilepsy syndrome	3.42e-05	0.000428	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—CCR5—epilepsy syndrome	3.41e-05	0.000427	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—GABBR1—epilepsy syndrome	3.41e-05	0.000426	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CHRM3—epilepsy syndrome	3.39e-05	0.000423	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GRM5—epilepsy syndrome	3.39e-05	0.000423	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCR3—epilepsy syndrome	3.34e-05	0.000418	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—HTR2A—epilepsy syndrome	3.34e-05	0.000418	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCR10—epilepsy syndrome	3.34e-05	0.000417	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—HRH3—epilepsy syndrome	3.27e-05	0.000409	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NPY—epilepsy syndrome	3.26e-05	0.000407	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ATP2A2—epilepsy syndrome	3.26e-05	0.000407	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CX3CR1—epilepsy syndrome	3.25e-05	0.000406	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—OPRM1—epilepsy syndrome	3.22e-05	0.000402	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CX3CL1—epilepsy syndrome	3.18e-05	0.000398	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—BDKRB1—epilepsy syndrome	3.18e-05	0.000398	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CHRM2—epilepsy syndrome	3.18e-05	0.000398	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—AGT—epilepsy syndrome	3.17e-05	0.000396	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—OXT—epilepsy syndrome	3.14e-05	0.000393	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CRH—epilepsy syndrome	3.14e-05	0.000393	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HSPB1—epilepsy syndrome	3.14e-05	0.000393	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CXCL2—epilepsy syndrome	3.14e-05	0.000393	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCL3—epilepsy syndrome	3.14e-05	0.000393	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CCR5—epilepsy syndrome	3.1e-05	0.000387	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—JUN—epilepsy syndrome	3.1e-05	0.000387	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GABBR1—epilepsy syndrome	3.1e-05	0.000387	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CCR3—epilepsy syndrome	3.04e-05	0.00038	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—HTR2A—epilepsy syndrome	3.03e-05	0.000379	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	3.02e-05	0.000378	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—HRH3—epilepsy syndrome	2.97e-05	0.000371	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—NPY—epilepsy syndrome	2.96e-05	0.00037	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	2.96e-05	0.00037	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CCR5—epilepsy syndrome	2.95e-05	0.000368	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.93e-05	0.000366	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—OPRM1—epilepsy syndrome	2.92e-05	0.000365	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TSC1—epilepsy syndrome	2.92e-05	0.000365	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PTK2B—epilepsy syndrome	2.92e-05	0.000365	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GRM2—epilepsy syndrome	2.92e-05	0.000365	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—HTR2A—epilepsy syndrome	2.88e-05	0.00036	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AGT—epilepsy syndrome	2.88e-05	0.00036	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—OXT—epilepsy syndrome	2.86e-05	0.000357	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CRH—epilepsy syndrome	2.86e-05	0.000357	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CXCL2—epilepsy syndrome	2.86e-05	0.000357	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCR2—epilepsy syndrome	2.84e-05	0.000355	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NTRK2—epilepsy syndrome	2.84e-05	0.000355	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SST—epilepsy syndrome	2.84e-05	0.000355	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—DUSP6—epilepsy syndrome	2.82e-05	0.000352	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADRA2A—epilepsy syndrome	2.78e-05	0.000348	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PLAT—epilepsy syndrome	2.77e-05	0.000346	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CCR3—epilepsy syndrome	2.76e-05	0.000345	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—AGT—epilepsy syndrome	2.74e-05	0.000342	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—NPY—epilepsy syndrome	2.69e-05	0.000336	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CXCL12—epilepsy syndrome	2.67e-05	0.000334	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—BDKRB2—epilepsy syndrome	2.67e-05	0.000334	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—POMC—epilepsy syndrome	2.67e-05	0.000333	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PRKCB—epilepsy syndrome	2.66e-05	0.000332	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—IL6ST—epilepsy syndrome	2.65e-05	0.000331	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SSTR3—epilepsy syndrome	2.64e-05	0.00033	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CNR1—epilepsy syndrome	2.62e-05	0.000328	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—JUNB—epilepsy syndrome	2.62e-05	0.000328	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PLCB1—epilepsy syndrome	2.61e-05	0.000327	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CCL3—epilepsy syndrome	2.59e-05	0.000324	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CRH—epilepsy syndrome	2.59e-05	0.000324	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—OXT—epilepsy syndrome	2.59e-05	0.000324	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CXCL2—epilepsy syndrome	2.59e-05	0.000324	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CCR2—epilepsy syndrome	2.58e-05	0.000323	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—SST—epilepsy syndrome	2.58e-05	0.000323	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ST3GAL3—epilepsy syndrome	2.58e-05	0.000323	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HTR7—epilepsy syndrome	2.56e-05	0.00032	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SSTR1—epilepsy syndrome	2.53e-05	0.000316	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCR8—epilepsy syndrome	2.53e-05	0.000316	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCR9—epilepsy syndrome	2.53e-05	0.000316	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NPY2R—epilepsy syndrome	2.53e-05	0.000316	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ARHGEF9—epilepsy syndrome	2.53e-05	0.000316	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	2.53e-05	0.000316	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HBEGF—epilepsy syndrome	2.48e-05	0.00031	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GRM3—epilepsy syndrome	2.48e-05	0.00031	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GRM4—epilepsy syndrome	2.48e-05	0.00031	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AKT3—epilepsy syndrome	2.44e-05	0.000305	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—DUSP4—epilepsy syndrome	2.44e-05	0.000304	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SSTR2—epilepsy syndrome	2.44e-05	0.000304	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	2.43e-05	0.000304	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CXCL12—epilepsy syndrome	2.43e-05	0.000304	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—POMC—epilepsy syndrome	2.42e-05	0.000303	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CNR1—epilepsy syndrome	2.38e-05	0.000298	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADAM10—epilepsy syndrome	2.38e-05	0.000298	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PLCB1—epilepsy syndrome	2.38e-05	0.000297	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CCL2—epilepsy syndrome	2.37e-05	0.000296	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GRM8—epilepsy syndrome	2.35e-05	0.000294	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PGF—epilepsy syndrome	2.35e-05	0.000294	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—SST—epilepsy syndrome	2.35e-05	0.000293	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CCR2—epilepsy syndrome	2.35e-05	0.000293	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—HTR7—epilepsy syndrome	2.33e-05	0.000291	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—POMC—epilepsy syndrome	2.3e-05	0.000288	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.3e-05	0.000287	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CCL2—epilepsy syndrome	2.25e-05	0.000282	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—S100B—epilepsy syndrome	2.25e-05	0.000281	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GNAO1—epilepsy syndrome	2.24e-05	0.00028	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—OPRD1—epilepsy syndrome	2.24e-05	0.00028	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SOCS3—epilepsy syndrome	2.23e-05	0.000279	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CDC42—epilepsy syndrome	2.22e-05	0.000278	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AKT3—epilepsy syndrome	2.22e-05	0.000277	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.21e-05	0.000276	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CXCL12—epilepsy syndrome	2.21e-05	0.000276	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CNR1—epilepsy syndrome	2.17e-05	0.000271	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PLCB1—epilepsy syndrome	2.16e-05	0.00027	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AVP—epilepsy syndrome	2.15e-05	0.000269	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PDYN—epilepsy syndrome	2.15e-05	0.000269	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GRM1—epilepsy syndrome	2.15e-05	0.000269	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCR7—epilepsy syndrome	2.15e-05	0.000269	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—HTR7—epilepsy syndrome	2.11e-05	0.000264	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—HBEGF—epilepsy syndrome	2.05e-05	0.000256	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HES1—epilepsy syndrome	2.04e-05	0.000255	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CDC42—epilepsy syndrome	2.02e-05	0.000253	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GAL—epilepsy syndrome	2.02e-05	0.000253	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GFAP—epilepsy syndrome	2.02e-05	0.000253	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AKT3—epilepsy syndrome	2.01e-05	0.000252	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CASP2—epilepsy syndrome	2e-05	0.00025	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CHRM3—epilepsy syndrome	2e-05	0.00025	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GRM5—epilepsy syndrome	2e-05	0.00025	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FYN—epilepsy syndrome	1.98e-05	0.000248	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—H2AFX—epilepsy syndrome	1.97e-05	0.000247	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MEF2C—epilepsy syndrome	1.97e-05	0.000246	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AVP—epilepsy syndrome	1.96e-05	0.000245	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.92e-05	0.00024	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.9e-05	0.000238	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NGF—epilepsy syndrome	1.88e-05	0.000235	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.88e-05	0.000235	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.88e-05	0.000235	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.88e-05	0.000235	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.84e-05	0.00023	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCR5—epilepsy syndrome	1.83e-05	0.000229	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.83e-05	0.000229	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HTR2A—epilepsy syndrome	1.79e-05	0.000224	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.78e-05	0.000222	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.75e-05	0.000219	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	1.73e-05	0.000216	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TSC2—epilepsy syndrome	1.7e-05	0.000213	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AGT—epilepsy syndrome	1.7e-05	0.000213	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—APOE—epilepsy syndrome	1.67e-05	0.000208	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.67e-05	0.000208	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—KDR—epilepsy syndrome	1.63e-05	0.000204	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.63e-05	0.000204	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.63e-05	0.000204	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	1.59e-05	0.000199	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.59e-05	0.000199	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PRKCB—epilepsy syndrome	1.57e-05	0.000196	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IL6ST—epilepsy syndrome	1.56e-05	0.000196	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.55e-05	0.000193	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	1.53e-05	0.000192	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	1.53e-05	0.000192	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.53e-05	0.000192	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.53e-05	0.000192	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.53e-05	0.000192	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.51e-05	0.000189	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.48e-05	0.000185	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—POMC—epilepsy syndrome	1.43e-05	0.000179	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.43e-05	0.000179	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.43e-05	0.000178	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.43e-05	0.000178	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.4e-05	0.000176	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCL2—epilepsy syndrome	1.4e-05	0.000175	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.39e-05	0.000173	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SST—epilepsy syndrome	1.39e-05	0.000173	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.39e-05	0.000173	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.37e-05	0.000172	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.36e-05	0.00017	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	1.35e-05	0.000169	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	1.3e-05	0.000163	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.3e-05	0.000163	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	1.3e-05	0.000163	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.3e-05	0.000162	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.29e-05	0.000162	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	1.28e-05	0.00016	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	1.28e-05	0.00016	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	1.27e-05	0.000159	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—FGF2—epilepsy syndrome	1.27e-05	0.000158	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	1.25e-05	0.000156	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	1.21e-05	0.000151	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	1.19e-05	0.000149	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	1.18e-05	0.000148	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—RELA—epilepsy syndrome	1.17e-05	0.000147	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	1.16e-05	0.000145	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	1.16e-05	0.000145	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MTOR—epilepsy syndrome	1.15e-05	0.000144	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	1.1e-05	0.000137	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	1.09e-05	0.000136	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	1.09e-05	0.000136	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.07e-05	0.000134	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CASP3—epilepsy syndrome	1.06e-05	0.000132	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	1.05e-05	0.000131	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—JUN—epilepsy syndrome	1.03e-05	0.000129	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MMP9—epilepsy syndrome	1e-05	0.000125	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	9.93e-06	0.000124	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AKT1—epilepsy syndrome	9.71e-06	0.000121	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	9.66e-06	0.000121	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	9.63e-06	0.00012	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	9.61e-06	0.00012	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	9.29e-06	0.000116	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SRC—epilepsy syndrome	9.23e-06	0.000115	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	9.18e-06	0.000115	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—VEGFA—epilepsy syndrome	8.99e-06	0.000112	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	8.93e-06	0.000112	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	8.74e-06	0.000109	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	8.3e-06	0.000104	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	8.29e-06	0.000104	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	8.13e-06	0.000102	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	7.96e-06	9.95e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	7.66e-06	9.58e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	7.63e-06	9.54e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	6.98e-06	8.73e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	6.83e-06	8.54e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	6.17e-06	7.72e-05	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AKT1—epilepsy syndrome	5.74e-06	7.17e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	5.73e-06	7.16e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	5.62e-06	7.02e-05	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.22e-06	6.52e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	5.17e-06	6.46e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	5.02e-06	6.28e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	4.88e-06	6.11e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	4.74e-06	5.92e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	4.5e-06	5.63e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	4.39e-06	5.48e-05	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.8e-06	3.5e-05	CbGpPWpGaD
